GlassScriptPhysician profile
Randi S Connor
NPI 1073801965
$3,411.58
in general payments reported to CMS, 2019-2025
24 companies · $912 in 2025
The $912 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $330 · 2021: $114 · 2022: $247 · 2023: $757 · 2024: $759 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,144 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,144.09 |
| Education | $283.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $618.73 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $584.81 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $464.77 | 2019-2025 | Lynparza |
| Glaxosmithkline, LLC. | $356.68 | 2020-2025 | Zejula, Jemperli |
| Daiichi Sankyo INC. | $275.36 | 2024-2025 | Enhertu, Injectafer |
| Abbvie INC. | $179.14 | 2024-2025 | |
| Eisai INC. | $159.35 | 2022-2025 | |
| Caldera Medical, INC | $148.81 | 2024 | Desara |
| Axonics, INC. | $110.45 | 2023 | Bulkamid, Axonics |
| Seagen INC. | $62.83 | 2022-2023 | Tivdak |
| Amgen INC. | $53.19 | 2019-2022 | |
| Clovis Oncology, INC. | $51.54 | 2019-2022 | |
| Smith+Nephew, INC. | $47.60 | 2024-2025 | Stravix, Stravix Pl |
| Janssen Pharmaceuticals, INC | $47.06 | 2019-2021 | |
| Baxter Healthcare | $39.18 | 2024 | Adept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $32.56 | 2019 | |
| Genentech USA, INC. | $30.15 | 2019 | |
| Immunogen, INC. | $29.63 | 2023 | Elahere |
| Tempus Ai, INC | $26.89 | 2024 | Xt Cdx |
| Dilon Technologies, INC. | $26.47 | 2025 | Hemoblast Bellows |
| Avanos Medical | $19.74 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.67 | 2024 | |
| Hologic Sales and Service, LLC | $14.69 | 2024 | Myosure Tissue Removal Device |
| Ethicon US, LLC | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randi Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.